European Respiratory Society - 32nd International Congress
Drugs of the Future
; 47(11):833-835, 2022.
Article
in English
| EMBASE | ID: covidwho-2227236
ABSTRACT
The 32nd European Respiratory Society (ERS) International Congress was held again in person at the FIRA Barcelona Gran Via Conference Center in Spain, as well as online. On-site attendance was limited to 10,000 delegates, with the spaces selling out before the conference began. The program included live streamed presentations, thematic poster discussion sessions, oral presentations, mini-symposia, industry exhibitors and skills workshops to discuss major respiratory fields that included thoracic oncology, respiratory infections, interstitial lung diseases, respiratory critical care, sleep and breathing disorders and pulmonary vascular diseases. This report will cover some of the most interesting presentations related to respiratory disease treatment. Copyright © 2022 Clarivate.
blu-5937; Molgramostim; rc-0315; sgn-001; Vilobelimab; autoimmune lung disease/dt [Drug Therapy]; chronic cough/dt [Drug Therapy]; conference paper; coronavirus disease 2019/dt [Drug Therapy]; drug efficacy; drug safety; fibrosing alveolitis/dt [Drug Therapy]; human; lung alveolus proteinosis/dt [Drug Therapy]; medical literature; medical society; nonhuman; phase 2 clinical trial (topic); phase 3 clinical trial (topic); respiratory tract disease/dt [Drug Therapy]; secretome; antifibrotic agent/dt [Drug Therapy]; beta1a interferon/ct [Clinical Trial]; beta1a interferon/dt [Drug Therapy]; beta1a interferon/ih [Inhalational Drug Administration]; molgramostim/dt [Drug Therapy]; purinergic P2X receptor antagonist/ct [Clinical Trial]; purinergic P2X receptor antagonist/dt [Drug Therapy]; respiratory tract agent/dt [Drug Therapy]; unclassified drug; vilobelimab/ct [Clinical Trial]; vilobelimab/dt [Drug Therapy]; blu 5937/ct [Clinical Trial]; blu 5937/dt [Drug Therapy]; rc 0315/dt [Drug Therapy]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Drugs of the Future
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS